Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EndoGastric Solutions has announced positive results at the completion of one-year follow-up on gastroesophageal reflux disease or GERD patients in the Phase II multi-center study of the first generation transoral incisionless fundoplication procedure and first-generation EsophyX device.
Subscribe to our email newsletter
The EsophyX device is said to enable surgeons and advanced interventional gastroenterologists to offer their patients substantive anatomical repair without incisions (no skin or internal dissection) for front-line surgical management of GERD patients.
Todd Overcash, medical director of Bariatric and Minimally Invasive Surgery at Munroe Regional Medical Center in Ocala, Florida, said: “With no skin incisions, no cutting of vessels, and no dissection of the fundus, the EsophyX device represents a new era in antireflux treatment and offers patients an innovative, state-of-the-art surgical procedure that will allow them to no longer live their lives pill-to-pill.”